. Author manuscript; available in PMC: 2012 Apr 1.

Published in final edited form as: AIDS Behav. 2011 Apr;15(Suppl 1):S66–S71. doi: 10.1007/s10461-011-9899-9

Table 1.

Completed or planned RM studies

Study	Stage and population characteristics	Product	Sponsor	Status
RMP-002/MTN-006	Phase 1 (sexually abstinent)	Vaginal tenofovir gel	NIH/DAIDS/IPCP Program	Completed
MTN-007	Phase 1 (sexually abstinent)	Reduced glycerin formulation of vaginal tenofovir	NIH/DAIDS/MTN	Q4 2010
Project Gel	Phase 1 (sexually active)	Reduced glycerin formulation of vaginal tenofovir	NIH/NICHD	Q2 2011
CHARM Program	Pre-Phase 1 (single dose, sexually abstinent)	Rectal specific tenofovir gel	NIH/DAIDS/IPCP Program	Q2 2011
MTN-017	Phase 1 (sexually abstinent)	Reduced glycerin formulation of vaginal tenofovir	NIH/DAIDS/MTN	Q4 2011